CTNM vs FCEL · $429.6M cap vs rev $99.1M
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) versus FuelCell Energy Inc (FCEL) — a side-by-side from cached financials, not a winner call.
Contineum Therapeutics, Inc. Class A Common Stock (CTNM) is a biotechnology company listed on US.
FuelCell Energy Inc (FCEL) is a electrical equipment & parts company listed on US.
Latest reported CTNM revenue for 2024-09-30 was $0. Net income was -$27.7M. CTNM currently screens at market cap $429.6M.
Latest reported FCEL revenue for 2026-07-31 was $99.1M. Net income was -$145.2M. Revenue was up 49.9% from 2026-04-30 to 2026-07-31. FCEL currently screens at market cap $130.8M.
CTNM currently screens at market cap $429.6M. FCEL currently screens at market cap $130.8M.
Not investment advice. Open the CTNM and FCEL stock pages for the full models.
Not investment advice.